RE:RE:RE:RE:RE:I wonder if the market Rumpl3StiltSkin wrote: To Thors original question, No!
They(markets) still need to connect the dots. TLT deserves a speculative rating, especially with all that is known over the last 3 weeks, above $1.
We have 'on good authority' that TLT is still under major consideration for that 2nd Lumeda phase 1 trial. They are now working with Canadas national lab on a Covid 19 vaccine/therapy. Li Ka Shing Institute has set TLT up with their own Cancer research lab, with all those implications.
If Laserstock was still aroud he'd probably argue for a spec value for TLT of $2. ;-)
CancerSlayer wrote: StevenBirch wrote: Correct, we "the few" do know it's capabilities and are emotionally attached to it but I think for this to catch fire we just need some results - updates on those that have been treated and additional enrollment numbers for starters - and they should come soon.
I think the last 2 announcements have put a rock solid floor under the stock but when we get good results I think they will be seen even more favorably and we should get a nice pop.
You are right Apophis, it is time to gorge but as for my position I'm already loaded up, I would be considered morbidly obese! I'm looking forward to the day where I can lighten up, hopefully soon.
99942Apophis wrote: Oden6570 wrote
Realize the upside of our tech. I mean Canada's main lab for virus research assisting and leading research to develop vaccine for the whole family of covid and other viruses This company has become much more valuable IMHO.
True enough Oden6570, it is baffling, my thoughts are maybe once media and stock analysts bring it to the forefront and its viewed as an incredible solution to medical science that can resolve the battle with cancer, viruses and bacteria the company (TLT) will be viewed by a few. We on the other hand "the few" already know its capabilities and are gorging on stock. My opinion here is this company (TLT) is on the verge of being know so I'm happy with having bought while it is still under $10? $20? $30? $100?
Hey SB...I'm pretty full too, but this is turning into a buffet & there's always room for a little more dessert. I plan to gorge a little on each new set of promising results (preclinical &/or clinical), especially when they're coming in from potentially "multiple" delicious indications. Your feeling "morbidly obese" is another's "fat & jolly" ; )
I'd be shocked if Roswell/Lumeda don't incorporate TLD-1433. The question is, which news will we hear first imo....animal data or a new trial using TLD-1433? Will be hard to hold this sp down much longer with so many coals in this fire. I also hope our new public/private collaboration re: vaccine development isn't too unidimensional from a scientific perspective. Would like to see considerations made on "various" fronts or forms of vaccination (injectable, nasal, oral)...need to block this virus from all angles, including working to provide maximal mucosal immunity = more ideal protection, which the latter two formulations would help provide.